Capital Research Global Investors Kronos Bio, Inc. Transaction History

Capital Research Global Investors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$11.35 - $21.18 $10.2 Million - $19 Million	-899,243 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$18.17 - $24.7 $34.4 Million - $46.8 Million	-1,895,866 Reduced 67.83%	899,243 $18.8 Million
Q2 2021 Aug 16, 2021	SELL	$20.08 - $29.02 $15 Million - $21.7 Million	-746,464 Reduced 21.08%	2,795,109 $66.9 Million
Q4 2020 Feb 12, 2021	BUY	$26.68 - $38.23 $94.5 Million - $135 Million	3,541,573 New	3,541,573 $103 Million

20.7M

31.4K

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $55.1M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

Stay updated on Capital Research Global Investors with notifications on news.